Goldpoint Clinical Research — Indianapolis, Indiana

Goldpoint Clinical Research is a clinical research site located in Indianapolis, Indiana, United States 46260.

Crixeo Clinical Trials Trust Score: 25/100 (FAILING). This profile has not yet been claimed by the site owner.

Goldpoint Clinical Research has participated in 35 clinical trials.

Therapeutic areas: Adult Attention Deficit Hyperactivity Disorder, Migraine Disorders, Attention-deficit/Hyperactivity Disorder.

Sponsors: Sumitomo Pharma America, Inc., Eli Lilly and Company, Shire.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Indianapolis

Browse all research sites in Indiana · View every site in Indianapolis

Sponsor Feasibility Report

Trust Score: 25/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Goldpoint Clinical Research?

Goldpoint Clinical Research has a Crixeo Trust Score of 25/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Goldpoint Clinical Research conducted?

Goldpoint Clinical Research has 35 clinical trials on record. Their work covers Adult Attention Deficit Hyperactivity Disorder, Migraine Disorders, Attention-deficit/Hyperactivity Disorder.

Is Goldpoint Clinical Research accredited by Crixeo Clinical Trials?

Goldpoint Clinical Research has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Goldpoint Clinical Research?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.